Regarding the use of methylation markers, a first study has reported that higher methylation of RASSF1A in plasma at diagnosis or one year after surgery was correlated with poorer DFS in 63 patients with resectable HCC. The gene discussed is RASSF1; the disease is hepatocellular carcinoma.